CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysis. (PubMed, Leuk Lymphoma) - May 18, 2026 - "This cohort reflects a predominantly in vivo T-cell-depleted transplant population in the pre-letermovir era...CMV reactivation was associated with lower relapse risk in patients with myeloid malignancy, although the biological basis of this association remains uncertain. Refractory CMV increases CMV-related mortality, but probable refractory CMV does not increase mortality risk."
Journal • Bone Marrow Transplantation • Cytomegalovirus Infection • Graft versus Host Disease • Hematological Malignancies • Immunology • Infectious Disease • Leukemia • Oncology • Transplantation
|
|
Arjun Law; Armin Gerbitz; Auro Viswabandya; Carol Chen; Dennis Dong Hwan Kim; Fotios V Michelis; Igor Novitzky-Basso; Ivan Pasic; Jeffrey H Lipton; Jonas Mattsson; Mats Remberger; Rajat Kumar; Vered Stavi; Wilson Lam
|